Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$4,079 Mln
Revenue (TTM)
$1,516 Mln
Net Profit (TTM)
$0 Mln
ROE
0.1 %
ROCE
-- %
P/E Ratio
32.2
P/B Ratio
2.5
Industry P/E
--
EV/EBITDA
13.1
Div. Yield
0 %
Debt to Equity
0.6
Book Value
$26.4
EPS
$2.1
Face value
--
Shares outstanding
59,431,931
CFO
$975.40 Mln
EBITDA
$893.07 Mln
Net Profit
$349.43 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Merit Medical Systems (MMSI)
| -22.6 | -11.6 | -22.6 | -35.5 | -2.6 | 2.6 | 13.9 |
|
BSE Sensex*
| -13.7 | -10.1 | -14.2 | -3.8 | 7.4 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Merit Medical Systems (MMSI)
| -8.9 | 27.1 | 7.6 | 13.4 | 12.2 | 77.8 | -44.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Merit Medical Systems (MMSI)
|
68.2 | 4,079.4 | 1,515.9 | 128.5 | 13.0 | 8.7 | 32.2 | 2.5 |
| 7.8 | 5,176.8 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 0.9 | |
| 36.1 | 5,222.6 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.1 | |
| 25.9 | 3,989.0 | 2,719.5 | 47.0 | 8.4 | 1.6 | 86.6 | 1.3 | |
| 112.6 | 6,098.9 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 8.9 | |
| 75.7 | 4,758.4 | 1,541.6 | 233.6 | 21.6 | 21.4 | 21.4 | 4.5 | |
| 178.0 | 9,411.8 | 1,526.9 | -151.5 | 20.0 | -17.1 | -- | 12.9 | |
| 329.0 | 12,879.6 | 1,403.7 | 177.7 | 14.7 | 13.8 | 72.5 | 9.2 | |
| 118.3 | 6,280.4 | 738.3 | 48.9 | 11.4 | 2.4 | 129.6 | 3.0 | |
| 32.1 | 13,409.8 | 6,178.4 | 626.5 | 13.0 | 11.9 | 22.1 | 2.6 |
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and... internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah. Address: 1600 West Merit Parkway, South Jordan, UT, United States, 84095 Read more
Founder, Chairman, CEO & President
Mr. Fred P. Lampropoulos
Founder, Chairman, CEO & President
Mr. Fred P. Lampropoulos
Headquarters
South Jordan, UT
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Merit Medical Systems Inc (MMSI) is $68.23 (NASDAQ) as of 01-Apr-2026 16:00 EDT. Merit Medical Systems Inc (MMSI) has given a return of -2.65% in the last 3 years.
The P/E ratio of Merit Medical Systems Inc (MMSI) is 32.23 times as on 31-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
41.18
|
3.34
|
|
2024
|
48.71
|
4.25
|
|
2023
|
46.97
|
3.69
|
|
2022
|
54.93
|
3.58
|
|
2021
|
74.09
|
3.45
|
The 52-week high and low of Merit Medical Systems Inc (MMSI) are Rs 107.27 and Rs 66.34 as of 02-Apr-2026.
Merit Medical Systems Inc (MMSI) has a market capitalisation of $ 4,079 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Merit Medical Systems Inc (MMSI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.70
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.